Keyphrases
Tuberculosis
100%
Recombinant
100%
T Cell Response
100%
Viral Vectors
100%
Tuberculosis Vaccine
100%
Pichinde Virus
100%
Cell Protection
100%
Virus Vector
75%
Protective Efficacy
75%
Mycobacterium Tuberculosis (M. tb)
50%
Vaccine Candidate
50%
MHC Class II
50%
Antigen-specific CD4 T Cells
50%
Vector-based
50%
ESAT-6
50%
Linker Sequence
50%
Lung T Cell
50%
Ag85B
50%
EsxA
50%
Lung Tissue
25%
Mouse Model
25%
Immunogenicity
25%
T Cell Immunity
25%
Immunization
25%
Immunogen
25%
Trivalent
25%
Arenavirus
25%
Vaccine Response
25%
Pregenomic RNA (pgRNA)
25%
Viral-vectored
25%
Viral-vectored Vaccine
25%
Non-pathogenic
25%
Vaccine Platform
25%
Upstream Open Reading Frame (uORF)
25%
Inoculation Route
25%
Intramuscular Route
25%
Pulmonary Tuberculosis
25%
Neutralization Activity
25%
Low Seroprevalence
25%
Global Health Issue
25%
Intranasal Route
25%
Antigen-specific CD8+ T Cells
25%
Aerosol Challenge
25%
Intranasal Inoculation
25%
Lung mucosa
25%
Intracellular Cytokine Staining
25%
Viral Vaccine Vector
25%
Tissue Burden
25%
Tetramer Analysis
25%
Vaccine-induced Immunity
25%
Immunology and Microbiology
Viral Vector
100%
BCG Vaccine
100%
Pichinde Virus
100%
T Cell
100%
Immunology
100%
T-Helper Cell
50%
Antigen Specificity
50%
Mycobacterium Tuberculosis
50%
Adoptive Immunity
25%
Cytotoxic T-Cell
25%
Immunogenicity
25%
Neutralization
25%
Intracellular Cytokine Staining
25%
Mouse Model
25%
Arenaviridae
25%
Virus Vaccine
25%
Seroprevalence
25%
Lung Mucosa
25%
Cytokine
25%
Open Reading Frame
25%